MedPath

Fetoscopic Selective Laser Photocoagulation in Twin-Twin Transfusion Syndrome

Not Applicable
Conditions
Twin to Twin Transfusion Syndrome
Registration Number
NCT00345852
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Brief Summary

This is a study to compare two treatments (amnioreduction vs. selective fetoscopic laser photocoagulation \[SFLP\]) in patients with severe twin to twin transfusion syndrome.

Detailed Description

We hypothesize that treatment of the underlying chorioangiopagus by selective fetoscopic laser photocoagulation will not only improve the survival of twins but will reduce the incidence of neurologic, cardiac, and developmental sequelae of twin-twin transfusion syndrome (TTTS). We propose to test this hypothesis by a prospective randomized multicenter trial to compare serial amnioreduction with selective fetoscopic laser photocoagulation in cases of severe (stage II-IV) twin-twin transfusion syndrome (TTTS). Primary Outcomes: Survival of donor twin at 30 days after birth and no treatment failure; Survival of recipient twin at 30 days after birth and no treatment failure; Secondary Outcomes: Survival times of each twin in utero or after birth (which may be censored at 30 days after birth); Gestational age at delivery; Placental insufficiency; Cardiac outcome: echocardiographic evidence of cardiac compromise; Neurologic outcome: evidence of brain injury preceding birth by MRI; Postnatal comorbidity

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
150
Inclusion Criteria
  • Both twins are alive
  • TTTS diagnosed prior to 22 weeks gestation
  • Monochorionic diamniotic gestation
  • Like sex twins
  • Single placental mass
  • Thin intertwin membrane
  • Oligohydramnios in donor twin (deepest vertical pocket of ≤ 2 cm)
  • Polyhydramnios with deepest vertical pocket of > 8 cm with or without Doppler or echocardiographic changes in the recipient twin (deepest vertical pocket of > 6 cm if previous amnioreduction)
  • Decompressed bladder in donor not seen to fill during the ultrasound examination (stage II, III, or IV), unless Doppler velocimetry changes (absent end-diastolic umbilical artery flow, abnormal ductus venosus waveform), and/or echocardiographic changes (valvular insufficiency, ventricular hypertrophy) are already present
  • No associated structural abnormalities
  • No sonographic evidence of CNS injury at time of entry
  • No preterm labor
  • No maternal medical contraindication to anesthesia or surgery
Exclusion Criteria
  • Failure to meet all inclusion criteria
  • TTTS presenting after 22 weeks gestation
  • Randomization after 24 weeks gestation
  • Cervical length < 2.0 cm post initial
  • Presence of cervical cerclage
  • Uterine anomaly
  • Refusal to accept randomization
  • Unable to pursue prenatal care at an approved center coordinated by one of the participating institutions
  • Unable to pursue postnatal evaluation at a NICHD Neonatal Research Network Institution

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Survival of donor twin at 30 days after birth and no treatment failure
Survival of recipient twin at 30 days after birth and no treatment failure
Secondary Outcome Measures
NameTimeMethod
Survival times of each twin in utero or after birth (which may be censored at 30 days after birth)
Gestational age at delivery
Placental insufficiency
Cardiac outcome: echocardiographic evidence of cardiac compromise
Neurologic outcome: evidence of brain injury preceding birth by MRI
Postnatal comorbidity

Trial Locations

Locations (12)

Eastern Virginia Medical School

🇺🇸

Norfolk, Virginia, United States

New York University School of Medicine

🇺🇸

New York, New York, United States

Columbia-Presbyterian Medical Center

🇺🇸

New York, New York, United States

University of California-San Francisco

🇺🇸

San Francisco, California, United States

Cincinnati Children's Hospital Medical Center

🇺🇸

Cincinnati, Ohio, United States

Children's Hospital of Philadelphia

🇺🇸

Philadelphia, Pennsylvania, United States

Magee-Women's Hospital

🇺🇸

Pittsburgh, Pennsylvania, United States

University of Texas Medical Branch

🇺🇸

Galveston, Texas, United States

University of Utah Hospital

🇺🇸

Salt Lake City, Utah, United States

University of Washington Medical Center

🇺🇸

Seattle, Washington, United States

Evanston Northwestern Healthcare

🇺🇸

Evanston, Illinois, United States

Good Samaritan Hospital

🇺🇸

Cincinnati, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath